Apo-Si-K170AC76(Interna Therapeutics Ltd)

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameApo-Si-K170AC76(Interna Therapeutics Ltd)
Drug Alias NameApo-Si-K170A-C76(Interna Therapeutics Ltd)C76(Interna Therapeutics Ltd)C76C76(Interna Therapeutics Ltd)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInterna Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInterna Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A